(Reuters) -Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment ...

Tear film stability, tear production, ocular surface health, and symptoms were all significantly improved with the use of ...

The eye drops are used to treat symptoms experienced by nearly 4 million Americans following an increasingly common procedure ...

Dry eye disease (DED) has been identified as a main driver for growth of the global eye drops market, which was projected to ...

Results from a study have shown that stem cell eye drops eased the signs and symptoms of dry eye disease in adults with and ...

Dry eye syndrome, a condition affecting millions of Americans each year, continues to present a frustrating challenge for ...

One night, something went seriously wrong with my eyes on a drive home. Four years later, I'm still trying to fix it.

A 56-year-old man presented for 3 weeks of intermittent blurred vision and photophobia.His medical history included type 2 diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

If you've been diagnosed with Demodex blepharitis, you may be interested in Xdemvy, the first and only FDA-approved ...